111
Views
3
CrossRef citations to date
0
Altmetric
SHORT REPORT

TNF gene polymorphisms in Graves’ disease: TNF-308 A/G meta-analysis

, , , , &
Pages 656-661 | Received 31 Jan 2008, Published online: 11 Nov 2008

References

  • Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves’ ophthalmopathy. Hum Immunol 2004; 65: 632–639
  • Badenhoop K, Schwarz G, Schleusener H, Weetman AP, Recks S, Peters H, Bottazzo GF, Usadel KH. Tumor necrosis factor beta gene polymorphisms in Graves’ disease. J Clin Endocrinol Metab 1992; 2: 287–291
  • Bahn RS, Garrity JA, Gorman CA. Clinical review 13: Diagnosis and management of Graves’ ophthalmopathy. J Clin Endocrinol Metab 1990; 71: 559–563
  • Bougacha-Elleuch N, Rebai A, Mnif M, Makni H, Bellassouad M, Jouida J, Abid M, Hammadi A. Analysis of MHC genes in a Tunisian isolate with autoimmune thyroid diseases: implication of TNF –308 gene polymorphism. J Autoimmun 2004; 1: 75–80
  • Caturegli P, Kimura H, Rocchi R, Rose NR. Autoimmune thyroid diseases. Curr Opin Rheumatol 2007; 19: 44–48
  • Chen RH, Chen WC, Wang TY, Tsai CH, Tsai FJ. Lack of association between pro-inflammatory cytokine (IL-6, IL-8 and TNF-alpha) gene polymorphisms and Graves’ disease. Int J Immunogenet 2005; 32: 343–347
  • Hunt PJ, Marshall SE, Weetman AP, Bunce M, Bell JI, Wass JA, Welsh KI. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin Endocrinol 2001; 4: 491–499
  • Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedospasov SA, Cambon-Thomsen A. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci U S A 1991; 88: 9717–9721
  • Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K. A polymorphism of the 5′ flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 2000; 52: 759–764
  • Kawazaki E. Sample preparation from blood, cells and other fluids. PCR protocols: a guide to methods and application, M Innis, D Gelffand, G Snisky, T. White. Academic Press, San Diego, CA 1990; 146–152
  • Kula D, Bednarczuk T, Jurecka-Lubieniecka B, Polanska J, Hasse-Lazar K, Jarzab M, Steinhof-Radwanska K, Hejduk B, Zebracka J, Kurylowicz A, Bar-Andziak E, Stechly T, Pawlaczek A, Gubala E, Krawczyk A, Szpak-Ulczok S, Nauman J, Jarzab B. Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves’ disease: the impact of DRB1*07. Thyroid 2006; 16: 447–453
  • Kula D, Jurecka-Tuleja B, Gubala E, Krawczyk A, Szpak S, Jarzab M. Association of polymorphism of LTalpha and TNF genes with Graves’ disease. Folia Histochem Cytobiol 2001; 39: 77–78
  • Maalej A, Hadj Kacem H, Bellassoued M, Abid M, Makni H, Ayadi H. Polymorphisms of HLA DQB1 CAR1/CAR2 and TNFalpha IR2/IR4 microsatellite markers in patients affected with Graves disease. Clin Immunol 2000; 2: 91–93
  • Rasmussen AK, Kayser L, Feldt-Rasmussen U, Bendtzen K. Influence of tumour necrosis factor-alpha, tumour necrosis factor-beta and interferon-gamma, separately and added together with interleukin-1 beta, on the function of cultured human thyroid cells. J Endocrinol 1994; 2: 359–365
  • Shiau MY, Huang CN, Yang TP, Hwang YC, Tsai KJ, Chi CJ, Chang YH. Cytokine promoter polymorphisms in Taiwanese patients with Graves’ disease. Clin Biochem 2007; 40: 213–217
  • Simmonds MJ, Heward JM, Howson JM, Foxall H, Nithiyananthan R, Franklyn JA, Gough SC. A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves’ disease. Genes Immun 2004; 5: 267–273
  • Song K, Robert CE. A powerful method of combining measures of association and Hardy–Weinberg disequilibrium for fine mapping in case control studies. Stat Med 2006; 25: 105–126
  • Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 5: 1162–1169
  • Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353
  • Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997; 94: 3195–3199
  • Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251–253

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.